GILZ inhibits the mTORC2/AKT pathway in BCR-ABL+ cellsSami Joha(Inserm), Thierry Idziorek(Inserm)OncogeneAugust 1, 201110.1038/onc.2011.328Cited by 44SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis